Big pharmaceutical companies are the one who says that they are committed to discovering new medicines and delivering medicinal breakthroughs to the patients who need them. But at what cost? Price gouging by the pharmaceutical industry is soaring exponentially. The US drug market is full of pharma players who organize aggressive pricing strategies for lifesaving drugs that are only intended to maximize their capital gains and shareholder profits. Quoting the example of the story of Martin Shkreli (the most hated man in America), the pharmaceutical tycoon known for raising the price of an AIDS and Malaria drug, Daraprim , by 5500% overnight, is just the initial glimpse of what is happening around the drug pricing and how pharma giants are manipulating the cost of a lifesaving drug. Another emphasizing example is Revlimid , the analogue of the infamous drug, thalidomide . The story of Revlimid’s development is unique, even uplifting. But the story of what it costs is all too familiar...
A subsidiary of AR EduX. As Pharmaceutical professionals and an indispensable part of medical sciences, we take it upon ourselves to recondition and fortify the current Pharmaceutical education scenario in society and provide the most relevant information to cure and treat the various Pathophysiological conditions related to human health.